Alzheimer's disease (AD) is a dementing illness, clinically characterized by a progressive memory loss, a decline in executive functions, and an impairment in conducting the activities of daily living. Many scientists believe that AD results from an increase in the production or accumulation of a specific protein in the brain (so-called beta-amyloid) that causes death of nerve cell. Loss of nerve cells in strategic brain areas, in turn, results in deficits of certain neurotransmitters, which are the brain's chemical messengers.
The main risk factor for AD is increased age. Other risk factors are genetic disposition, oxidative stress as well as a number of medical conditions such as depression or cerebrovascular diseases.
Rapid advances in basic scientific and clinical knowledge have led to the development of specific drugs against AD. Tulsa Clinical Research, LLC in Tulsa, Oklahoma, is currently conducting various research studies with promising new agents for the treatment of patients in all severity stages of Alzheimer's disease.
To request more information about clinical trials and Alzheimer's disease, please submit the form below.
By signing up for clinical trials, you are playing a more active role in your own healthcare, while also paving the way for better treatment options for others with Alzheimer’s disease. Go to alz.org/TrialMatch or call (800) 272-3900 today to find a trial near you.
Alzheimer’s Association TrialMatch is a free, confidential interactive tool that provides comprehensive clinical trial information and an individualized trial matching service for people with Alzheimer’s disease and related dementias. Alzheimer’s Association TrialMatch operates through the Internet (www.alz.org/TrialMatch), and through the Alzheimer’s Association toll-free phone number (800-272-3900). This powerful tool is also available to caregivers, physicians, researchers and people interested in becoming “healthy volunteers.”